Taysha Gene Therapies TSHA

$ 1.86 0.27%

Quarterly report 2024-Q3
added 11-13-2024

Taysha Gene Therapies EV/EBITDA Ratio 2011-2024 | TSHA

Annual EV/EBITDA Ratio Taysha Gene Therapies

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-1.13	-1.25	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.13	-1.25	-1.19